Rigel Pharmaceuticals Photos

Lobby
Cafeteria
Rigel Building

+ Add Photo

Rigel Pharmaceuticals Reviews

3.6
Rating Trends
Recommend to a friend
Approve of CEO
(no image)
Raul Rodriguez
0 Ratings
  • Great place to work

    • Work/Life Balance
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Rigel Pharmaceuticals full-time

    Pros

    family like environment, interesting science, nice people

    Cons

    family like environment, department dependant advancement opportunities


Rigel Pharmaceuticals Interviews

Interview Experience

Interview Experience

0%
100%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Pharmaceuticals Interview

    Anonymous Employee
    No Offer
    Neutral Experience
    Average Interview

    Application

    I applied online. The process took 2 daysinterviewed at Rigel Pharmaceuticals in June 2010.

    Interview

    Very organized HR department.

    Interview Questions

Rigel Pharmaceuticals Awards & Accolades

Something missing? Add an award
Best Places to Work in the Bay Area (Mid-Size Companies), San Francisco Business Times and Silicon Valley/San Jose Business Journal, 2011
Best Places to Work in the Bay Area, San Francisco Business Times, 2012

Additional Info

Website www.rigel.com
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public (RIGL)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year
Competitors Unknown

When immune systems attack, Rigel Pharmaceuticals wants to be there. The drug discovery and development firm focuses its research and development efforts on inflammatory/autoimmune, muscle, and metabolic diseases. Drugs in development include candidates for treating rheumatoid arthritis, psoriasis, muscle wasting, multiple sclerosis, and transplant rejection. Rigel prefers to collaborate with larger pharmaceutical companies in the development of its drug candidates. Rigel Pharmaceuticals went public through a $140 million IPO in 2011. The company intends to use the funds... More

Work at Rigel Pharmaceuticals? Share Your Experiences

Rigel Pharmaceuticals

 
Click to Rate
or